Rtw Investments, LP Exagen Inc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Exagen Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,511,866 shares of XGN stock, worth $10.9 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,511,866
Previous 1,511,866
-0.0%
Holding current value
$10.9 Million
Previous $6.2 Million
12.44%
% of portfolio
0.09%
Previous 0.1%
Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
40Shares Held
6.13MCall Options Held
3.4KPut Options Held
18.4K-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$6.4 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.82 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$3.52 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$3.49 Million0.0% of portfolio
-
Perkins Capital Management Inc423KShares$3.04 Million1.69% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $117M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...